Home
Search
Category
Compounds
Status
Download
Contacts
Resources



Compound category: Organic compounds
(total 903 related compounds in database, current show from 581 to 590)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
N-(5-chloro-2-methylphenyl)-2-(4-oxo-3(4H)-quinazolinyl)acetamide Depiction based on curated SMILES O N N CH 3 O N H Cl Mycobacterium Immune modulation Preclinical (in vitro) Karanja CW, et al. 2021. ACS Infect Dis
N-[(FURAN-2-YL)METHYL]-N'-{1-[4-(4-METHOXYPHENYL)PIPERAZIN-1-YL]-1-(THIOPHEN-2-YL)PROPAN-2-YL}ETHANEDIAMIDE Depiction based on curated SMILES O O H 3 C HN O HN O S N CH 3 N Mycobacterium Exoenzyme Preclinical (in vitro) Chen L, et al. 2010. ACS Med Chem Lett
N-[(Z)-(2,4-dihydroxyphenyl)methylideneamino]-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide Depiction based on curated SMILES NH OH OH N O HN N Mycobacterium Motility Preclinical (in vitro) Ouertatani-Sakouhi H, et al. 2017. PLoS One
N-[(Z)-(2-hydroxy-3-prop-2-enylphenyl)methylideneamino]-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide Depiction based on curated SMILES N H N CH 2 O N H N HO Mycobacterium Motility Preclinical (in vitro) Ouertatani-Sakouhi H, et al. 2017. PLoS One
N'-[(Z)-(5-BROMO-2-HYDROXYPHENYL)METHYLIDENE]-4,5,6,7-TETRAHYDRO-1H-INDAZOLE-3-CARBOHYDRAZIDE Depiction based on curated SMILES HN OH Br N O NH N Mycobacterium Motility Preclinical (in vitro) Ouertatani-Sakouhi H, et al. 2017. PLoS One
1-[2-[(4-fluorophenyl)methylamino]-2-oxo-ethyl]-N-[1-(4-methyl-5-vinyl-1H-imidazol-2-yl)ethyl]-6-oxo-pyridine-3-carboxamide Depiction based on curated SMILES H 2 C F NH O CH 3 O N O NH H 3 C N H N Mycobacterium Exoenzyme Preclinical (in vitro) Mori M, et al. 2014. Bioorg Med Chem Lett
S-(2,4-difluorophenyl) 2-[5-[4-(trifluoromethyl)phenyl]tetrazol-2-yl]ethanethioate Depiction based on curated SMILES O F F F F F S N N N N Mycobacterium Motility Preclinical (in vitro) Ouertatani-Sakouhi H, et al. 2017. PLoS One
[2,4-Dihydroxy-3-(3-methyl-2-buten-1-yl)phenyl][(1R,2S,6S)-6-(2,4-dihydroxyphenyl)-2-[4-[(1E)-2-(2,4-dihydroxyphenyl)ethenyl]-2,6-dihydroxyphenyl]-4-methyl-3-cyclohexen-1-yl]methanone Depiction based on curated SMILES HO H 3 C CH 3 OH HO OH OH OH H H H CH 3 HO OH O Mycobacterium Exoenzyme Preclinical (in vitro) Mascarello A, et al. 2013. PLoS One
3-{[4-(dimethylamino)-2-pyridin-3-yl-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]carbonyl}phenol Depiction based on curated SMILES O N OH CH 3 N N N H 3 C N Mycobacterium Immune modulation Preclinical (in vitro) Karanja CW, et al. 2021. ACS Infect Dis
(4-(4-bromo-3,5-bis(trifluoromethyl)phenylcarbamoyl)phenyl)difluoromethylphosphonic acid Depiction based on curated SMILES HO OH O P F F F F F Br F F F NH O Mycobacterium Exoenzyme Preclinical (in vitro) Rawls KA, et al. 2009. Bioorg Med Chem Lett
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page 1  ...  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66  67  68  69  ...  91



Back to top
2004-2025 NIPB, CAMS&PUMC